ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 78 filers reported holding ORCHARD THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is 13.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $356,000 | -17.0% | 712,001 | -2.9% | 0.00% | – |
Q2 2022 | $429,000 | -19.7% | 733,547 | -2.2% | 0.00% | – |
Q1 2022 | $534,000 | -35.4% | 749,990 | +19.9% | 0.00% | – |
Q4 2021 | $826,000 | -45.0% | 625,512 | -4.2% | 0.00% | – |
Q3 2021 | $1,502,000 | -49.4% | 652,833 | -3.4% | 0.00% | – |
Q2 2021 | $2,966,000 | -22.5% | 675,716 | +28.1% | 0.00% | – |
Q1 2021 | $3,829,000 | +64.8% | 527,374 | -2.0% | 0.00% | – |
Q4 2020 | $2,324,000 | -19.6% | 537,971 | -23.5% | 0.00% | – |
Q3 2020 | $2,891,000 | -32.1% | 703,497 | -0.9% | 0.00% | – |
Q2 2020 | $4,259,000 | +56.8% | 709,895 | +96.8% | 0.00% | – |
Q1 2020 | $2,716,000 | -47.7% | 360,752 | -4.5% | 0.00% | – |
Q4 2019 | $5,197,000 | +606.1% | 377,940 | +618.6% | 0.00% | – |
Q2 2019 | $736,000 | – | 52,592 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 2,931,185 | $12,047,000 | 4.29% |
RA Capital Management | 12,315,213 | $50,616,000 | 0.93% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $28,562,000 | 0.70% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 620,233 | $2,549,000 | 0.35% |
Casdin Capital, LLC | 1,870,000 | $7,686,000 | 0.34% |
Vivo Capital, LLC | 1,325,736 | $5,449,000 | 0.32% |
Bleichroeder LP | 250,000 | $1,028,000 | 0.18% |
Virtus ETF Advisers LLC | 40,292 | $166,000 | 0.09% |
Forefront Analytics, LLC | 30,369 | $123,000 | 0.06% |
PLATINUM INVESTMENT MANAGEMENT LTD | 411,977 | $1,693,000 | 0.04% |